{"cik":1649989,"taxonomy":"us-gaap","tag":"LongTermDebt","label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","entityName":"OUTLOOK THERAPEUTICS, INC.","units":{"USD":[{"end":"2015-09-30","val":2922764,"accn":"0001571049-16-016287","fy":2016,"fp":"Q2","form":"10-Q","filed":"2016-06-27"},{"end":"2015-09-30","val":2922764,"accn":"0001571049-16-017518","fy":2016,"fp":"Q3","form":"10-Q","filed":"2016-08-15"},{"end":"2015-09-30","val":2922764,"accn":"0001571049-16-020882","fy":2016,"fp":"FY","form":"10-K","filed":"2016-12-29","frame":"CY2015Q3I"},{"end":"2016-03-31","val":2547139,"accn":"0001571049-16-016287","fy":2016,"fp":"Q2","form":"10-Q","filed":"2016-06-27","frame":"CY2016Q1I"},{"end":"2016-06-30","val":2370267,"accn":"0001571049-16-017518","fy":2016,"fp":"Q3","form":"10-Q","filed":"2016-08-15","frame":"CY2016Q2I"},{"end":"2016-09-30","val":2881481,"accn":"0001571049-16-020882","fy":2016,"fp":"FY","form":"10-K","filed":"2016-12-29","frame":"CY2016Q3I"},{"end":"2017-09-30","val":203710,"accn":"0001571049-17-008779","fy":2017,"fp":"FY","form":"10-K","filed":"2017-12-29","frame":"CY2017Q3I"},{"end":"2018-09-30","val":164967,"accn":"0001144204-18-065142","fy":2018,"fp":"FY","form":"10-K","filed":"2018-12-18"},{"end":"2018-09-30","val":164967,"accn":"0001104659-19-074095","fy":2019,"fp":"FY","form":"10-K","filed":"2019-12-19","frame":"CY2018Q3I"},{"end":"2019-09-30","val":1076453,"accn":"0001104659-19-074095","fy":2019,"fp":"FY","form":"10-K","filed":"2019-12-19"},{"end":"2019-09-30","val":1076453000,"accn":"0001558370-20-010682","fy":2020,"fp":"Q3","form":"10-Q","filed":"2020-08-14","frame":"CY2019Q3I"},{"end":"2020-06-30","val":967055000,"accn":"0001558370-20-010682","fy":2020,"fp":"Q3","form":"10-Q","filed":"2020-08-14","frame":"CY2020Q2I"}]}}